Skip to content
Tirzepatide Report
Provider review

VitaFusions IV Tirzepatide Review: Price and Texas Access

Researched & written by Alan PierceClinical Pharmacology WriterUpdated

On this page

Texas weight-loss program advertising a $189 any-dose tirzepatide offer; confirm the supplied period and actual order.

Standout details

  • Named tirzepatide program card advertises $189 at any dose
  • Advertises no memberships, monthly contracts or automatic drafts

Things to consider

  • The $189 named card does not establish a monthly supplied period or continuing bill
  • Free initial advisor conversation does not establish every clinical consultation fee

VitaFusions IV advertises a $189 any-dose tirzepatide program, alongside a separate $149 any-dose semaglutide program. The named card is a program advertisement, rather than an itemized prescription invoice. Confirm the supplied quantity, period covered and actual amount due before treating the headline as your continuing bill.3

For the distinction between a compounded preparation and an approved product, see our compounded tirzepatide legal-status guide.

Start with the named program card

The homepage has a general “starting at $149 a month” headline covering weight-loss services. That is not a $149 tirzepatide quote. The treatment page separately names tirzepatide at $189 and advertises no memberships, no monthly contracts and no automatic drafts. Those statements describe the offer; ask how the actual order and later refill authorization work.3,4

VitaFusions IV: distinguish the two named programs

Published itemWhat it establishes
Tirzepatide$189 any-dose program card
Semaglutide$149 any-dose program card; different medication
Payment claimsNo memberships, monthly contracts or automatic drafts advertised
Actual supply and billConfirm the prescription quantity, supplied period and next authorization
The named program cards and general homepage starting headline answer different price questions.3,4

Texas access and the care process

The program says it serves Dallas–Fort Worth and all Texas. It describes an initial free conversation with a patient-care advisor, followed by a clinician telehealth visit and medication delivery. A free advisor consultation does not establish the cost or outcome of every subsequent clinical service. Confirm eligibility at your physical location and what the selected price includes.3

Ask about refills and the dispensing pharmacy

Obtain the prescriber and dispensing pharmacy's contact details, the actual formulation and supplied quantity, refill timing, and the process for stopping future orders. No-auto-drafts advertising should not be turned into an assumed refund policy or guaranteed lifelong price. A public pharmacy name would still not establish the facility assigned to a particular prescription.3

The published Terms identify Vitafusions IV Texas LLC and include SMS and general website provisions. Stopping SMS messages is a different action from canceling treatment or requesting a medication refund. The reviewed page does not establish a medication-specific refund deadline or a refund of an unused supplied period.5

For a subscription comparison, our Injectco review covers a named $425-per-month tirzepatide program advertising medication, supplies, consultations and monthly delivery. Its FAQ asks patients to contact the practice before the next delivery to cancel. Compare that monthly description with VitaFusions IV’s $189 card, whose supplied period still needs confirmation; neither headline establishes your actual prescription or refund rights.3,7

VitaFusions IV: questions before payment

QuestionPublic information
Where is care advertised?Dallas–Fort Worth and all Texas
How does care begin?Free advisor consultation, then clinician telehealth visit
What is the refund cutoff?Medication-specific cutoff not established by the reviewed general Terms
Program geography and general Terms do not establish personal eligibility or a prescription refund.3,5

Clinical evidence and the actual product

Clinical studies concern specific products and treatment protocols. They do not establish outcomes for this service or equivalence of an individual compounded preparation.1,2 If a compounded preparation is prescribed, it is not an FDA-approved finished medicine.6 Confirm the actual prescription, supplied quantity and dispensing instructions with the prescriber and pharmacist.

The tirzepatide evidence guide explains the research context. Discuss the side-effect profile, gallbladder risks and thyroid cancer warning with the prescribing clinician; a seller’s price does not determine clinical suitability.

Compare the care and payment commitment

For a different care arrangement, compare the published service and payment details in our Ondra Health review and Vita Bella review. A similar headline price does not establish the same supplied quantity or clinician access.

Use the tirzepatide provider comparison to compare published medication options and payment terms.

Frequently asked questions

Is VitaFusions IV tirzepatide advertised at $149?

The named tirzepatide card says $189 any dose. The separate semaglutide card and general starting-price headline say $149. Confirm the actual supplied period and bill.

Does VitaFusions IV advertise automatic drafts?

Its program cards advertise no automatic drafts, no monthly contracts and no memberships. Obtain the authorization and cancellation rules for the actual order.

Where does VitaFusions IV advertise service?

The program names Dallas–Fort Worth and all Texas. Confirm the applicable clinician and service at your physical location.

References(7)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
  3. VitaFusions IV (2026). Medical weight-loss program: named cards, payment claims and Texas coverage. VitaFusions IV.
  4. VitaFusions IV (2026). Homepage: general starting-price headline. VitaFusions IV.
  5. VitaFusions IV Texas LLC (2026). Terms and Conditions: SMS and general website terms. VitaFusions IV Texas LLC.
  6. U.S. Food and Drug Administration (2026). FDA concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration. Read source
  7. Injectco (2026). Tirzepatide delivery: named monthly program, inclusions and cancellation FAQ. Injectco.

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.